Singapore markets closed

Spectral AI, Inc. (MDAIW)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
0.1609+0.0089 (+5.86%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.1520
Open0.1698
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.1561 - 0.1698
52-week range0.1561 - 0.1698
Volume9,252
Avg. volumeN/A
Market capN/A
Beta (5Y monthly)0.55
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Spectral AI Appoints Jeremiah Sparks as Chief Commercialization Officer

    Experienced Burn Industry Executive Champions Pivot to CommercializationDALLAS, April 01, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the appointment of Jeremiah A. Sparks as Chief Commercialization Officer. Jeremiah has more than 20 years of medical device marketing experience, including global mark

  • GlobeNewswire

    Spectral AI Announces 2023 Fourth Quarter and Full Year Financial Results

    2023 Research & Development Revenue of $18.1 Million Expected to Increase to $28.0 Million in 2024 Commercialization Underway with Revenue Expected in 2H 2024 for DeepView AI®-Burn Indication in the UK On Track for Additional Regulatory Submissions in US and UK for DeepView™ System Burn and Diabetic Foot Ulcer Indications DALLAS, March 27, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnos

  • GlobeNewswire

    Spectral AI Secures Access to $12.5 Million of New Equity Capital

    Issuance of Convertible Instrument Balances Certainty, Timing, and ExecutionCapital Supports Strategic Imperatives and Commercialization Initiatives DALLAS, March 20, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has entered into a fixed price prepaid advance and standby equity purchase agreeme